SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 515 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $839,477 | +52.1% | 3,957 | +38.0% | 0.00% | +100.0% |
| Q2 2023 | $551,976 | -68.6% | 2,868 | -67.0% | 0.00% | -75.0% |
| Q1 2023 | $1,757,845 | -20.6% | 8,682 | -50.4% | 0.00% | -20.0% |
| Q4 2022 | $2,213,566 | -53.6% | 17,511 | -49.8% | 0.01% | -58.3% |
| Q3 2022 | $4,772,000 | -30.9% | 34,872 | -10.7% | 0.01% | -25.0% |
| Q2 2022 | $6,908,000 | -21.7% | 39,044 | -37.1% | 0.02% | -5.9% |
| Q1 2022 | $8,822,000 | -60.9% | 62,075 | -57.4% | 0.02% | -58.5% |
| Q4 2021 | $22,544,000 | -59.3% | 145,821 | -56.2% | 0.04% | -60.2% |
| Q3 2021 | $55,345,000 | -6.3% | 332,679 | -11.7% | 0.10% | +1.0% |
| Q2 2021 | $59,054,000 | -16.0% | 376,713 | -25.7% | 0.10% | -11.3% |
| Q1 2021 | $70,300,000 | +15.7% | 507,141 | +46.2% | 0.12% | +6.5% |
| Q4 2020 | $60,739,000 | – | 346,804 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |